DOVEINTEL
MI

MIRIAM

Cure Cancer
Solanapump.funLaunched 7h agopumpfun
AExdMwnstjpjH6p8wYjPUQRtTyyonGU357e1YCY3pumpExplorer
64/ 100
Dove Trust Score
Caution

Mixed or incomplete evidence

Confidence100%

How much of the verification rubric we could actually evaluate. Unknown data never counts as safe.

Contract safety100 · 4/4
Liquidity & market81 · 7/7
Holder distribution93 · 5/5
Identity & community53 · 5/5
Provenance & reputation75 · 3/3
Dove brief

Cure Cancer ($MIRIAM) on Solana has been trading for 7 h via pump.fun.

Dove Trust Score 64/100: Caution (confidence 100%).

Strengths: Not flagged as rugged. Mint authority is revoked: supply is fixed. Liquidity sits on the launchpad's bonding curve and cannot be withdrawn by the creator.

Concerns: Website links to different accounts than the listing (X @ticaonsol). Possible clone: website copy identical to 1 other token(s); artwork reused by 20 other token(s). $8.0K: shallow pool.

Mixed evidence. Several signals are weak or missing; treat as speculative until the gaps close.

Ask Dove about this token
Red flags & warnings
  • Reciprocal link verification med
    Website links to different accounts than the listing (X @ticaonsol).
  • Originality med
    Possible clone: website copy identical to 1 other token(s); artwork reused by 20 other token(s).
  • Liquidity depth
    $8.0K: shallow pool.
  • Insider networks
    1 linked insider network(s) detected among early wallets.
  • Social presence
    Only one social channel linked.
  • Contract shown on website
    Contract address not found on the website.
Price
$0.0₅5346
-4.6%
Liquidity
$8.0K
Market cap
$5.3K
FDV $5.3K
Volume 24h
$124.7K
Holders
344
Trades 24h
2.6K
59% buys
1h change
+0.1%
Market & trust history
$0.0₅5346
Oct 20, 01:03 PM

Verification report

Contract safety
4 checks
Liquidity & market
7 checks
Holder distribution
5 checks
Identity & community
5 checks
Provenance & reputation
3 checks

More from this deployer

Possible clones

Last verified 19 minutes ago · Sources: jupiter, dexscreener · Automated analysis, not financial advice. How scoring works